Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-04

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract including Crohn's disease and Ulcerative Colitis. The course of IBD is frequently progressive and can be hardly predictable, with sudden exacerbations of intestinal symptoms. Epidemiological studies have shown that IBD has an increasing prevalence to reach 10 million people in 2030. These diseases require frequent interactions between patients and the healthcare system, or symptom management with continuous therapies, gastroenterological visits, surgery, contacts for resolution of urgent symptoms from telephone and email, access to the emergency, hospitalizations, nutritional counseling, psychological interventions and follow-up controls. An IBD can completely disrupt a family's ability to function normally and often imposes a strain on family members' relationships. In the model of self-care in chronic diseases, according to Riegel's "Middle Range Theory", there are external factors, predictive factors that can influence and limit the patient's attitude and therefore his self-esteem, the ability to implement decision-making behaviors to improve and increase his self-care. There are also factors that influence a person's self-care decisions: the particular caregivers. In this process, the role of the caregiver and the dyad he establishes with the patient can influence the whole process of self-confidence and self-care. The objectives of the study are to investigate and describe self-care in patients with IBD and how their caregivers in dyadic interaction can contribute.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease

NCT03239704

Inflammatory Bowel Disease Ulcerative Colitis Crohn Disease

UNKNOWN NA

Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.

NCT05835973

Disease Bowel Crohn Disease Ulcerative Colitis

RECRUITING NA

Biological Therapy in Patients With Inflammatory Bowel Disease

NCT05599867

Quality of Life

UNKNOWN

Assessing Cardiovascular Dysfunction Pre- & Post-treatment in Inflammatory Bowel Diseases

NCT03615287

Inflammatory Bowel Diseases

UNKNOWN

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

NCT05733845

Crohn's Disease Ulcerative Colitis

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study design Multicentre prospective observational study

Population The study is multicentre and will be conducted at the Fondazione Policlinico Gemelli IRCCS in Rome as the reference centre together with the centres that decide to participate. Patients will be enrolled at the IBD centres, in the medical wards, during visits or during hospitalization. Follow-up will be after the first administration at T1 (6 months) and T2 (12 months). Subsequent questionnaires (T1 and T2) will be administered by telephone or telematically. The study will start as soon as it is approved by the Ethics Committee. The total duration of the study will not exceed 12 months from the last enrolment.

Duration of the study The study will last 12 months from the date of approval by the Ethics Committee. The study is hypothetically expected to be completed by the end of December 2024.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammatory Bowel Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Administration of questionnaires for the evaluation of self-care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 or older;
* voluntary participation in the study;
* patient with the diagnosis of IBD outpatients and non-hospitalized;
* caregiver of patients with IBD diagnosis outpatients and hospitalised;
* Reading and signing informed consent

Exclusion Criteria

* patients with a diagnosis of IBD for less than 12 months;
* caregivers of patients with an IBD diagnosis for fewer than 12 months;
* patients operated for less than 6 months; care providers of patients operating less than six months;
* reduced mastery of the Italian language;
* subjects suffering from serious psychiatric disorders;
* serious clinical conditions that would not allow the completion of the questionnaire;
* refusal to sign the informed consent to participate in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes